Back
BioStem Technologies, Inc. 10K Form
Sell
30
BSEM
BioStem Technologies, Inc.
Last Price:
$4.5700
Seasonality Move:
8.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BSEM News And Ratings
See the #1 stock for the next 7 days that we like better than BSEM
BSEM Financial Statistics
Sales & Book Value
| Annual Sales: | $47.5M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 9.13 |
| Annual Sales: | $2.33 |
| Price / Book: | 2.15 |
Profitability
| EPS (TTM): | 0.16970 |
|---|---|
| Net Income (TTM): | $-6.6M |
| Gross Margin: | $44.2M |
| Return on Equity: | -14.58% |
| Return on Assets: | -6.39% |
BioStem Technologies, Inc. Earnings Forecast
Key BioStem Technologies, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for BSEM is 93.13%.
-
The Selling, General & Administrative Expenses for BSEM have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 14.92% of Revenue.
-
The Net Earning history of BSEM is -13.86% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 10 years.
BioStem Technologies, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | BSEM |
| Website: | biostemtechnologies.com |
Debt
| Debt-to-Equity Ratio: | 0.09 |
|---|---|
| Current Ratio: | 4.12 |
| Quick Ratio: | 3.66 |
Price-to-Earnings
| Trailing P/E Ratio: | 3.48 |
|---|---|
| Forward P/E Ratio: | 13.1 |
BSEM Technical Analysis vs Fundamental Analysis
Sell
30
BioStem Technologies, Inc. (BSEM)
is a Sell
Is BioStem Technologies, Inc. a Buy or a Sell?
-
BioStem Technologies, Inc. stock is rated a SellThe current BioStem Technologies, Inc. [BSEM] share price is $4.5670. The Score for BSEM is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.